A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail
Status:
Completed
Trial end date:
2017-07-07
Target enrollment:
Participant gender:
Summary
Several properties of VT-1161 suggest that it might be a safer and more effective treatment
for onychomycosis of the toenail (also known as toenail fungus) than other oral antifungal
medicines.
This study will evaluate the effectiveness and safety of VT-1161 for the treatment of toenail
onychomycosis and consists of a screening phase, a 24-week treatment phase in which the
patient will take either active drug, placebo or a combination of the 2 (according to random
assignment), an initial observational phase of 36 weeks and an additional observational study
extension of 9 months.
The additional 9-month observational study extension was added with a protocol amendment and
patient participation was optional.